ASLAN Pharmaceuticals’ $42 Million Initial Public Offering

Cooley advised ASLAN Pharmaceuticals Limited on its $42 million initial public offering of 6,000,000 American Depositary Shares, each representing five ordinary shares. Leerink Partners and Piper…